17.11.2021 23:03:27
|
Moderna Seeks FDA's Emergency Use Authorization Of COVID-19 Booster Shots
(RTTNews) - Drug maker Moderna Inc. (MRNA) Wednesday announced that it has filed an application with the U.S. Food and Drug Administration seeking emergency use authorization of its Covid-19 booster vaccine shots for all adults ages 18 and up.
The company's booster vaccine for adults "regardless of occupational risk factors" is already authorized in many international markets, Moderna said in a statement.
The FDA had last month approved a third Moderna vaccine booster shot for everyone 65 years and older as well as other adults who are at higher risk of catching the virus and received their second dose more than six months prior.
If approved, the authorization would allow tens of millions of Americans to get a third vaccine dose, as data shows that the vaccine loses efficacy over the time.
Meanwhile, a panel of Centers for Disease Control and Prevention is set to meet this Friday to discuss data regarding Pfizer-BioNTech's request for approval of the booster shots. According to New York Times, the FDA might authorize booster doses of the Pfizer-BioNTech vaccine as early as Thursday.
Pfizer's booster dose, like Moderna's, were previously approved by FDA for older people as well as others with high-risk. Meanwhile, people ages 18 and older who have received Johnson & Jonson's single-dose vaccine are eligible for a booster.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Moderna Incmehr Nachrichten
20.12.24 |
Freitagshandel in New York: NASDAQ 100 zum Start des Freitagshandels schwächer (finanzen.at) | |
19.12.24 |
Donnerstagshandel in New York: NASDAQ 100 zum Ende des Donnerstagshandels in der Verlustzone (finanzen.at) | |
19.12.24 |
S&P 500-Titel Moderna-Aktie: So viel hätten Anleger an einem Moderna-Investment von vor einem Jahr verloren (finanzen.at) | |
19.12.24 |
Starker Wochentag in New York: NASDAQ 100-Börsianer greifen zum Handelsstart zu (finanzen.at) | |
18.12.24 |
Pluszeichen in New York: S&P 500 startet in der Gewinnzone (finanzen.at) | |
18.12.24 |
Schwacher Wochentag in New York: NASDAQ 100 liegt zum Start im Minus (finanzen.at) | |
16.12.24 |
Börse New York: S&P 500-Börsianer greifen zum Start des Montagshandels zu (finanzen.at) | |
16.12.24 |
Börse New York: Zum Start des Montagshandels Gewinne im NASDAQ 100 (finanzen.at) |
Analysen zu Moderna Incmehr Analysen
19.11.24 | Moderna Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
05.08.24 | Moderna Sector Perform | RBC Capital Markets | |
12.01.24 | Moderna Outperform | RBC Capital Markets | |
03.11.23 | Moderna Buy | Goldman Sachs Group Inc. |